<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-157516" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Sterile Pyuria</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sherchan</surname>
            <given-names>Robin</given-names>
          </name>
          <aff>Baylor College of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hamill</surname>
            <given-names>Richard</given-names>
          </name>
          <aff>Baylor College of Medicine; Michael E. DeBakey VA Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Robin Sherchan declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Richard Hamill declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>12</day>
          <month>8</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-157516.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Sterile pyuria is a medical condition characterized by the persistence of leukocytes in urine without bacteriuria. Pyuria is characterized by a urine sample containing greater than or equal to 10 white blood cells (WBCs) per mm&#x000b3;, unspun urine with&#x000a0;more than 3 WBC per high power field (WBC/HPF), or a urine dipstick analysis showing leukocyte esterase or nitrites.<xref ref-type="bibr" rid="article-157516.r1">[1]</xref>&#x000a0;Sterile pyuria occurs when any of these criteria are met without significant bacteriuria on urine culture, defined as greater than or equal to 10<sup>5</sup>&#x000a0;colony-forming units (CFUs) per mL.</p>
        <p>Advanced testing methods, such as next-generation sequencing (NGS), have shown that sterile pyuria may not necessarily indicate the absence of bacteria.<xref ref-type="bibr" rid="article-157516.r2">[2]</xref>&#x000a0;Research by Wolfe et al has suggested the existence of bacteria in the urinary tract that may constitute a natural microbiome.<xref ref-type="bibr" rid="article-157516.r3">[3]</xref> Nevertheless,&#x000a0;sterile pyuria remains a common and challenging condition to differentiate from a true urinary tract infection (UTI) in clinical practice. In addition to being a diagnostic challenge, definite guidelines regarding the management of sterile pyuria have not been established, contributing to the prevalence of inappropriate treatment of this condition.</p>
      </sec>
      <sec id="article-157516.s2" sec-type="Etiology">
        <title>Etiology</title>
        <p>Sterile pyuria is not a diagnosis but rather a term that encompasses a wide array of conditions, each requiring distinct management approaches or recommendations.<xref ref-type="bibr" rid="article-157516.r4">[4]</xref> Contrary to what the name implies, sterile pyuria is not always aseptic and can be caused by several infectious organisms, including <italic toggle="yes">Mycobacterium tuberculosis</italic>, viruses, fungi, and protozoan species, as well as atypical bacteria (such as&#x000a0;<italic toggle="yes">Chlamydia trachomatis</italic>&#x000a0;and&#x000a0;<italic toggle="yes">Ureaplasma urealyticum</italic>), which do not grow on conventional culture media.<xref ref-type="bibr" rid="article-157516.r5">[5]</xref></p>
        <p>Sexually transmitted infections (STIs)&#x000a0;caused by&#x000a0;<italic toggle="yes">C trachomatis</italic>,<italic toggle="yes"> Neisseria gonorrhoeae,</italic> and&#x000a0;<italic toggle="yes">Trichomonas vaginalis</italic>&#x000a0;are especially significant in adolescent patients presenting with sterile pyuria.<xref ref-type="bibr" rid="article-157516.r6">[6]</xref><xref ref-type="bibr" rid="article-157516.r7">[7]</xref>&#x000a0;Infections outside the urinary tract, including pelvic inflammatory disease, appendicitis, diverticulitis, pneumonia, and sepsis, have also been associated with sterile pyuria, likely secondary to external genitourinary tract inflammation leading to leukocyte transluminal migration.<xref ref-type="bibr" rid="article-157516.r5">[5]</xref><xref ref-type="bibr" rid="article-157516.r8">[8]</xref></p>
        <p>Noninfectious causes of sterile pyuria include inflammatory conditions such as Kawasaki disease, systemic lupus erythematosus, and sarcoidosis, as well as conditions that compromise the immune system, including poorly controlled diabetes, chronic corticosteroid therapy, malignancy, AIDS, and renal transplant graft rejection. Other causes include drug-induced nephropathy and iatrogenic factors such as contrast dye, radiation cystitis, and indwelling urinary catheters.<xref ref-type="bibr" rid="article-157516.r5">[5]</xref></p>
        <p>Eosinophiluria is a distinct form of pyuria and can be associated with conditions such as allergic interstitial nephritis, cystitis, urinary tract obstruction, immunoglobulin A (IgA) nephropathy, cholesterol emboli, and contrast-induced acute renal failure. Additionally, urine contamination during specimen collection can lead to false positive results for sterile pyuria, either by showing no bacteriuria or by revealing polymicrobial growth on urine culture.</p>
      </sec>
      <sec id="article-157516.s3" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Sterile pyuria is not an uncommon laboratory finding, with up to 13.9% of females and 2.6% of males affected, based on population-based studies. Certain patient populations, including immunocompromised individuals and those hospitalized with infections unrelated to the urinary tract, have even higher prevalence rates.&#x000a0;Notably, approximately 87.5% of patients with acute appendicitis and 72.7% of those with acute diverticulitis were found to have sterile pyuria.<xref ref-type="bibr" rid="article-157516.r8">[8]</xref><xref ref-type="bibr" rid="article-157516.r9">[9]</xref><xref ref-type="bibr" rid="article-157516.r10">[10]</xref></p>
      </sec>
      <sec id="article-157516.s4" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Clinical evaluation should include a detailed history and physical examination to identify factors contributing to sterile pyuria and potential underlying etiologies. The assessment should cover social, sexual, family, and travel history, as well as any recent infections, antibiotic use, surgeries, or other invasive procedures. The presence of localized urinary symptoms, such as dysuria or hematuria, may suggest a renal or genitourinary origin of sterile pyuria. In contrast, more generalized symptoms, including fatigue, edema, joint pain, or skin rash, could indicate an underlying systemic pathology.<xref ref-type="bibr" rid="article-157516.r11">[11]</xref>&#x000a0;</p>
        <p>The physical examination should involve a detailed abdominal and pelvic assessment to check for localized inflammation, such as suprapubic or costovertebral angle tenderness, and systemic signs like pallor, organomegaly, or lymphadenopathy. If an STI is suspected, genital cultures should be performed.&#x000a0;</p>
      </sec>
      <sec id="article-157516.s5" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Before proceeding with further investigation, clinicians should ensure that the urine specimen has been correctly obtained using the appropriate collection technique. Contamination from normal flora at the urethral meatus or leukocytes present in vaginal secretions can lead to a false finding of sterile pyuria.<xref ref-type="bibr" rid="article-157516.r11">[11]</xref> Repeating the urinalysis is advisable, ensuring the urine is collected as a midstream clean-catch sample. Complete blood counts and chemistry panels should be routinely obtained as adjunctive tests, as they may offer early indications of underlying systemic disease processes.</p>
        <p>Based on the patient's history and physical examination, further evaluation is necessary to exclude differential diagnoses, such as genitourinary tuberculosis (GU-TB) or STIs. In addition,&#x000a0;it is recommended that genital cultures or urine specimens be collected to test for&#x000a0;<italic toggle="yes">C trachomatis</italic> and <italic toggle="yes">N gonorrhoeae</italic>. For patients from high-prevalence TB regions or those with significant TB exposure, 3 consecutive midstream clean-catch urine samples should be provided for acid-fast bacillus (AFB) staining and polymerase chain reaction (PCR). Additionally, renal, bladder, and abdominal imaging should be considered for symptomatic patients.<xref ref-type="bibr" rid="article-157516.r12">[12]</xref>&#x000a0;</p>
        <p>
<bold>Genitourinary Tuberculosis&#x000a0;</bold>
</p>
        <p>GU-TB is the most common form of extrapulmonary TB, accounting for approximately 30% of such cases, and typically arises from the systemic spread of primary pulmonary disease. GU-TB should be considered in individuals at increased risk, including those with a family history or epidemiological exposure to TB, immigrants, and immunocompromised patients (e.g., those with diabetes or HIV). GU-TB can affect various parts of the genitourinary tract, presenting with a diverse array of symptoms, such as dysuria, flank pain, lower urinary tract symptoms, and hematuria. Furthermore, GU-TB may be associated with constitutional symptoms, including fever, weight loss, anorexia, and night sweats. In some cases, infertility may occur due to TB involvement of the reproductive organs, leading to obstruction or scarring.<xref ref-type="bibr" rid="article-157516.r13">[13]</xref>&#x000a0;Sterile pyuria may be detected in up to 46% of males with GU-TB, with an increased prevalence observed in individuals experiencing immunosuppression, such as organ transplant recipients or those with HIV infection.</p>
        <p>Recognizing GU-TB can be challenging, as conventional urine cultures are not conducive to mycobacterial growth. The gold standard for diagnosing GU-TB is the AFB urine culture or culture from a tissue biopsy sample. However, AFB urine culture alone has a sensitivity rate of only 37% to 79%. To improve diagnostic accuracy, collecting at least 3 consecutive first-void morning urine samples for AFB cultures is recommended, which increases sensitivity to 80% to 90% and ensures nearly 100% specificity. Although isolating a specific organism provides critical data on drug susceptibility, the culture results can take up to 8 weeks. Newer PCR techniques offer variable sensitivity, ranging from 25% to 93%, with high specificity of 95% to 100%. A nucleic acid amplification test (NAAT) in urine for GU-TB allows for early and rapid diagnosis while awaiting culture and susceptibility data.<xref ref-type="bibr" rid="article-157516.r10">[10]</xref><xref ref-type="bibr" rid="article-157516.r14">[14]</xref></p>
        <p>Radiological findings can significantly aid in the diagnosis&#x000a0;of renal TB. Renal calcification is observed in approximately 40% to 70% of renal TB cases, with computerized tomography (CT) being the most sensitive method for detecting these calcifications. Additional CT findings may include various patterns of ureteral stricture, scarring, calyceal blunting, or hydronephrosis. Ultrasonography is less sensitive than CT for evaluating GU-TB.<xref ref-type="bibr" rid="article-157516.r15">[15]</xref>&#x000a0;Prostatic TB may also present with sterile pyuria, which can be the only clinical sign. Diagnosis of prostatic TB often occurs incidentally during transurethral prostatectomy or at autopsy. Prostate massage can obtain secretions for AFB culture, but this test is positive in only 36% of cases. PCR evaluation of prostatic secretions should also be considered for a more accurate diagnosis.<xref ref-type="bibr" rid="article-157516.r10">[10]</xref></p>
        <p>
<bold>Sexually Transmitted Infections&#x000a0;</bold>
</p>
        <p>STIs can&#x000a0;lead to sterile pyuria because traditional culture methods often fail to detect the causative organisms. Clinicians frequently order urine studies as part of the initial diagnostic workup for STIs due to the considerable symptom overlap between UTIs and STIs. In a survey by Shipman et al, 1052 patients&#x000a0;were diagnosed with either&#x000a0;<italic toggle="yes">C trachomatis</italic>,&#x000a0;<italic toggle="yes">N gonorrhoeae</italic>, or&#x000a0;<italic toggle="yes">T vaginalis</italic>. Among these patients, 389 (37%) exhibited pyuria, of which 74% exhibited sterile pyuria. Despite only 101 out of the 1052 urine cultures returning positive results, antibiotics were prescribed to 295 patients for suspected UTIs, highlighting significant antibiotic overuse in these cases.<xref ref-type="bibr" rid="article-157516.r16">[16]</xref>&#x000a0;</p>
        <p>Current tests of the most common STIs are simple, accurate, and cost-effective. The preferred method for STI&#x000a0;testing for women is a vaginal swab or first-catch urine sample, whereas a first-catch urine specimen sent for NAAT is the preferred method for men; however, urethral swabs may also be considered.<xref ref-type="bibr" rid="article-157516.r17">[17]</xref>&#x000a0;If STIs are suspected, it is essential to assess the patient and any sexual partners for HIV.</p>
        <p>
<bold>Viral Infections</bold>
</p>
        <p>Viral infections, including herpes simplex virus and HIV, may present with pyuria. Urethritis and cervicitis caused by herpes simplex virus 2 can lead to sterile pyuria; diagnosis is typically based on identifying vesicular lesions during physical examination and confirmed through cell culture or PCR assay. A study on untreated HIV found that 14 of 104 patients (13%) had pyuria.<xref ref-type="bibr" rid="article-157516.r18">[18]</xref><xref ref-type="bibr" rid="article-157516.r12">[12]</xref>&#x000a0;Less frequently encountered viruses, such as cytomegalovirus, Epstein-Barr virus, BK virus (human polyomavirus 1), and adenovirus, are more common in immunocompromised patients. These viral infections are occasionally associated with pyuria, with hemorrhagic cystitis being the most common presentation.</p>
        <p>
<bold>Fungal Infections&#x000a0;</bold>
</p>
        <p>Risk factors for fungal infections, such as <italic toggle="yes">Candida</italic>, <italic toggle="yes">Aspergillus</italic>, and <italic toggle="yes">Cryptococcus</italic>, include immunosuppression, organ and bone marrow transplantation, diabetes, and prolonged courses of multiple antibiotics or glucocorticoids. Individuals living in regions where coccidioidomycosis, blastomycosis, and histoplasmosis are endemic, particularly in the Southwest and Midwest, are at a higher risk for these infections. Diagnosis typically involves microscopic examination of urine to identify budding yeast or hyphae, urine fungal cultures, and, in some cases, bladder and prostate biopsies. Radiological assessments can also be helpful, particularly for detecting filling defects such as fungal balls in the bladder and renal masses.<xref ref-type="bibr" rid="article-157516.r12">[12]</xref>&#x000a0;</p>
        <p>
<bold>Parasitic Infections</bold>
</p>
        <p>Schistosomiasis affects the urogenital system in approximately 75% of infected individuals. Those who have lived in or traveled to Africa, particularly sub-Saharan and southern Africa, are at increased risk due to exposure to freshwater sources. Diagnosis is often made through microscopic examination of urine for&#x000a0;<italic toggle="yes">Schistosoma haematobium</italic>&#x000a0;eggs, biopsy of the bladder, and antischistosomal antibody testing. PCR is also being increasingly used for accurate diagnosis.<xref ref-type="bibr" rid="article-157516.r19">[19]</xref>&#x000a0;</p>
        <p>The most prevalent nonviral STI is&#x000a0;<italic toggle="yes">T vaginalis</italic>. Traditionally, the preferred diagnostic test involved identifying the motile parasite through a wet-mount preparation of genital secretions in women and urethral discharge in men, which&#x000a0;was less sensitive compared to culture. Currently, NAAT is the gold standard for diagnosing&#x000a0;<italic toggle="yes">T vaginalis</italic>&#x000a0;infections due to its high sensitivity and specificity. NAAT detects the genetic material of&#x000a0;<italic toggle="yes">T vaginalis</italic>, allowing for accurate identification even in cases with low organism load. These tests can be performed using vaginal, endocervical, or urine specimens.<xref ref-type="bibr" rid="article-157516.r20">[20]</xref></p>
        <p>
<bold>Inflammation Outside the Urinary Tract</bold>
</p>
        <p>In 2014, Hooker et al reported that 31 out of 210 patients (15%) hospitalized for infections unrelated to the urinary tract exhibited sterile pyuria. These infections included bacterial septicemia, pneumonia, and intraabdominal infections. Conditions such as urinary stones, radiation cystitis, renal transplant rejection, ureteral stents, urinary fistulae, and intrinsic renal disease can also be associated with pyuria. Therefore, further evaluation based on clinical risk factors is essential to exclude these potential etiologies.<xref ref-type="bibr" rid="article-157516.r8">[8]</xref></p>
        <p><bold>Systemic Inflammatory Diseases</bold>&#x000a0;</p>
        <p>Sterile pyuria, along with proteinuria and microscopic hematuria, is commonly seen in Kawasaki disease with renal involvement. In these cases, sterile pyuria may result from mild or subclinical renal injury affecting either the kidney or urethra. However, a UTI should be ruled out if urinalysis shows a positive nitrite test or if the urine culture is positive. Systemic lupus erythematosus can also present with sterile pyuria; isolated sterile pyuria has been reported in approximately 23% of patients with systemic lupus erythematosus.<xref ref-type="bibr" rid="article-157516.r21">[21]</xref><xref ref-type="bibr" rid="article-157516.r12">[12]</xref></p>
        <p>
<bold>Malignancy&#x000a0;</bold>
</p>
        <p>Genitourinary malignancies, such as bladder, kidney, and prostate cancer, can be associated with sterile pyuria. In these cases, pyuria has been studied as a potential marker for tumor recurrence and treatment response.<xref ref-type="bibr" rid="article-157516.r22">[22]</xref>&#x000a0;However, the relationship between pyuria, urinary microbiome, and genitourinary malignancies requires further investigation.</p>
        <p>
<bold>Urinary Tract Stones</bold>
</p>
        <p>Sterile pyuria can also indicate the presence of staghorn calculi, as noted in a 1992 study by Rowen et al. Evaluation typically involves imaging to confirm the presence of these large kidney stones.</p>
      </sec>
      <sec id="article-157516.s6" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The management of sterile pyuria is primarily guided by the underlying etiology. Infectious causes are typically treated with antimicrobials, with specific regimens tailored to the identified infectious species (see&#x000a0;<bold>Table.</bold>&#x000a0;Antimicrobials for Infectious Etiologies of Sterile Pyuria).</p>
        <table-wrap id="article-157516.table0" position="float" orientation="portrait">
          <caption>
            <title>Table. Antimicrobials for Infectious Etiologies of Sterile Pyuria</title>
          </caption>
          <table style="width: 800px;" border="1" cellspacing="1" cellpadding="4">
            <tbody>
              <tr style="height: 13px;">
                <td style="width: 187px; height: 13px;" rowspan="1" colspan="1">
<bold>Etiologies</bold>
</td>
                <td style="width: 645.422px; height: 13px;" rowspan="1" colspan="1">
<bold>Antimicrobial Regimens</bold>
</td>
              </tr>
              <tr style="height: 40px;">
                <td style="width: 187px; height: 40px;" rowspan="1" colspan="1">Genitourinary tuberculosis&#x000a0;</td>
                <td style="width: 645.422px; height: 40px;" rowspan="1" colspan="1">The initial drug regimen typically involves a combination of rifampin, isoniazid, ethambutol, and pyrazinamide, administered for 3 to 6 months using various dosing schedules. Please see StatPearls' companion resource, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://dev2.statpearls.com/point-of-care/30659">Genitourinary Tuberculosis</ext-link>," for further information.</td>
              </tr>
              <tr style="height: 49px;">
                <td style="width: 187px; height: 49px;" rowspan="1" colspan="1">
<italic toggle="yes">C trachomatis</italic>
</td>
                <td style="width: 645.422px; height: 49px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Doxycycline 100 mg twice a day orally for 7 days, or</p></list-item><list-item><p>Azithromycin 1 g orally in a single dose.</p></list-item></list>
</td>
              </tr>
              <tr style="height: 49px;">
                <td style="width: 187px; height: 49px;" rowspan="1" colspan="1">Gonorrhea&#x000a0;</td>
                <td style="width: 645.422px; height: 49px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Ceftriaxone 250 mg intramuscularly, and</p></list-item><list-item><p>Azithromycin 1 g orally once or&#x000a0;doxycycline 100 mg twice a day orally for 7 days.</p></list-item></list>
</td>
              </tr>
              <tr style="height: 62px;">
                <td style="width: 187px; height: 62px;" rowspan="1" colspan="1">
<italic toggle="yes">Mycoplasma genitalium&#x000a0;</italic>
</td>
                <td style="width: 645.422px; height: 62px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Oral doxycycline 100 mg twice daily for 7 days followed by oral azithromycin 1 g once. Then 500 mg daily for 3 days.</p></list-item><list-item><p>Alternatively, oral moxifloxacin 400 mg daily for 7 days for macrolide-resistant cases.</p></list-item></list>
</td>
              </tr>
              <tr style="height: 87px;">
                <td style="width: 187px; height: 87px;" rowspan="1" colspan="1">Genital herpes</td>
                <td style="width: 645.422px; height: 87px;" rowspan="1" colspan="1">
<p>Any one of the following:</p>
<list list-type="bullet"><list-item><p>Acyclovir 400 mg orally 3 times a day for 7 to 10 days.</p></list-item><list-item><p>Valacyclovir 1 g orally twice daily for 7 to 10 days.</p></list-item><list-item><p>Famciclovir 250 mg orally 3 times a day for 7 to 10 days.</p></list-item></list>
</td>
              </tr>
              <tr style="height: 73px;">
                <td style="width: 187px; height: 73px;" rowspan="1" colspan="1">Trichomoniasis</td>
                <td style="width: 645.422px; height: 73px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Oral metronidazole 500 mg twice daily for 7 days, or</p></list-item><list-item><p>2 g in a single dose.</p></list-item></list>
<p>Sexual partners need to be treated as well.</p>
</td>
              </tr>
              <tr style="height: 40px;">
                <td style="width: 187px; height: 40px;" rowspan="1" colspan="1">Fungal infections</td>
                <td style="width: 645.422px; height: 40px;" rowspan="1" colspan="1">Treatment includes antifungal drugs such as azoles, echinocandins, and amphotericin B based on fungal species and drug susceptibilities. Multiple antifungals may be required in patients with immunosuppression, diabetes mellitus, and a history of organ or bone marrow transplantation.</td>
              </tr>
              <tr style="height: 13px;">
                <td style="width: 187px; height: 13px;" rowspan="1" colspan="1">Schistosomiasis</td>
                <td style="width: 645.422px; height: 13px;" rowspan="1" colspan="1">
<p>Oral praziquantel&#x02014;dosing is adjusted based on the clinical presentation and specific <italic toggle="yes">Schistosoma</italic> species.</p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec id="article-157516.s7" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Differential diagnoses for sterile pyuria include a range of infectious and noninfectious etiologies, as mentioned below.</p>
        <list list-type="bullet">
          <list-item>
            <p>Infectious causes include:
<list list-type="bullet"><list-item><p>Recent treatment for&#x000a0;UTIs</p></list-item><list-item><p>Urethritis caused by&#x000a0;<italic toggle="yes">N gonorrhoeae</italic>, <italic toggle="yes">C trachomatis</italic>, or&#x000a0;<italic toggle="yes">M genitalium</italic></p></list-item><list-item><p>Genitourinary tuberculosis</p></list-item><list-item><p>Parasitic infections (eg, trichomoniasis or schistosomiasis)</p></list-item><list-item><p>Genitourinary tract infections due to viruses and fungi</p></list-item><list-item><p>Gynecologic infections</p></list-item><list-item><p>Balanitis</p></list-item><list-item><p>Prostatitis</p></list-item><list-item><p>Appendicitis&#x000a0;</p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Noninfectious causes include:
<list list-type="bullet"><list-item><p>Malignant hypertension (hematuria is usually associated with pyuria)</p></list-item><list-item><p>Systemic inflammatory diseases (eg, Kawasaki disease and sarcoidosis)</p></list-item><list-item><p>Glomerulopathy related to cyanotic congenital heart disease</p></list-item><list-item><p>Pregnancy</p></list-item><list-item><p>Indwelling urinary catheters</p></list-item><list-item><p>Recent urological procedures</p></list-item><list-item><p>Foreign objects, such as a retained stent or a surgical mesh in the urethra</p></list-item><list-item><p>Urinary tract pathology (eg, stones, neoplasm, fistula, and polycystic kidney disease)</p></list-item><list-item><p>Renal transplant rejection</p></list-item><list-item><p>Renal vein thrombosis</p></list-item><list-item><p>Interstitial cystitis or bladder pain syndrome</p></list-item><list-item><p>Papillary necrosis</p></list-item><list-item><p>Drug-related causes (eg, analgesic nephropathy or interstitial nephritis)&#x000a0;<xref ref-type="bibr" rid="article-157516.r5">[5]</xref><xref ref-type="bibr" rid="article-157516.r12">[12]</xref></p></list-item></list>
</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-157516.s8" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Sterile pyuria typically resolves with accurate diagnosis and targeted management of the underlying pathology, especially when caused by infectious agents. However, resolution may not occur in chronic inflammatory conditions, immunosuppression, or malignancy, where ongoing disease processes lead to persistent leukocyte extrusion into the genitourinary tract. In many cases, the degree of pyuria correlates with disease burden, notably in patients with non-muscle invasive bladder cancer, where preoperative pyuria has been identified as a predictive factor for cancer recurrence following transurethral resection.<xref ref-type="bibr" rid="article-157516.r23">[23]</xref></p>
      </sec>
      <sec id="article-157516.s9" sec-type="Complications">
        <title>Complications</title>
        <p>Complications of sterile pyuria can arise from its misinterpretation as a UTI, resulting in inappropriate initiation of antibiotic therapy. Empiric antibiotics commonly prescribed for UTIs often offer limited or no coverage against bacteria-causing STIs (eg,&#x000a0;<italic toggle="yes">C trachomatis</italic> or <italic toggle="yes">N gonorrhea</italic>)&#x000a0;and may contribute to antibiotic resistance. Misdiagnosis can also delay the recognition and treatment of GU-TB, allowing the disease to progress. Untreated GU-TB can result in extensive strictures along the genitourinary tract, leading to obstructive symptoms and potential sequelae such as hydroureter, hydronephrosis, and renal failure.<xref ref-type="bibr" rid="article-157516.r24">[24]</xref></p>
      </sec>
      <sec id="article-157516.s10" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>While clinician awareness of the various etiologies and differential diagnoses of sterile pyuria is crucial, counseling patients on the significance of follow-up and surveillance testing based on clinical suspicion is equally important. Patients should be reassured that the presence of sterile pyuria does not necessarily indicate a severe underlying pathology and may often be due to a benign cause.&#x000a0;</p>
      </sec>
      <sec id="article-157516.s11" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Sterile pyuria presents a diagnostic challenge for healthcare practitioners, requiring a multidisciplinary approach to ensure effective management and optimal patient outcomes. Physicians, advanced practitioners, nurses, pharmacists, and other health professionals must collaborate to achieve accurate diagnoses and implement appropriate treatment strategies. Detailed patient histories, physical examinations, and thorough investigations are essential, with an understanding that sterile pyuria involves the presence of leukocytes in urine without significant bacteriuria. Advanced testing methods, such as next-generation sequencing, can identify underlying bacteria that traditional cultures may miss.&#x000a0;Effective interprofessional communication is crucial to consider all potential causes, including GU-TB, STIs, viral infections, and systemic diseases.</p>
        <p>Physicians&#x000a0;lead the diagnostic process, while advanced practitioners and nurses are crucial for documenting patient history, collecting specimens, and providing patient education. Pharmacists&#x000a0;are critical in managing and advising on antimicrobial therapies tailored to specific infections identified. Care coordination involves timely referrals to specialists when initial evaluations do not clarify the underlying cause, ensuring comprehensive patient care. This integrated approach enhances patient-centered care, improves safety by reducing misdiagnoses and inappropriate antibiotic use, and fosters team performance through shared knowledge and responsibilities. Through interprofessional collaboration, healthcare teams can effectively navigate the complexities of sterile pyuria, ultimately improving patient outcomes.</p>
      </sec>
      <sec id="article-157516.s12">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=157516&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=157516">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/kidney-health/sterile-pyuria/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=157516">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/157516/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=157516">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-157516.s13">
        <title>References</title>
        <ref id="article-157516.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Horan</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Andrus</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dudeck</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.</article-title>
            <source>Am J Infect Control</source>
            <year>2008</year>
            <month>Jun</month>
            <volume>36</volume>
            <issue>5</issue>
            <fpage>309</fpage>
            <page-range>309-32</page-range>
            <pub-id pub-id-type="pmid">18538699</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157516.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xu</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Deebel</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Casals</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Dutta</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mirzazadeh</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>A New Gold Rush: A Review of Current and Developing Diagnostic Tools for Urinary Tract Infections.</article-title>
            <source>Diagnostics (Basel)</source>
            <year>2021</year>
            <month>Mar</month>
            <day>09</day>
            <volume>11</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">33803202</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157516.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wolfe</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Toh</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Shibata</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rong</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kenton</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Fitzgerald</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mueller</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Schreckenberger</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Dong</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Brubaker</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Evidence of uncultivated bacteria in the adult female bladder.</article-title>
            <source>J Clin Microbiol</source>
            <year>2012</year>
            <month>Apr</month>
            <volume>50</volume>
            <issue>4</issue>
            <fpage>1376</fpage>
            <page-range>1376-83</page-range>
            <pub-id pub-id-type="pmid">22278835</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157516.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stamm</surname>
                <given-names>WE</given-names>
              </name>
            </person-group>
            <article-title>Measurement of pyuria and its relation to bacteriuria.</article-title>
            <source>Am J Med</source>
            <year>1983</year>
            <month>Jul</month>
            <day>28</day>
            <volume>75</volume>
            <issue>1B</issue>
            <fpage>53</fpage>
            <page-range>53-8</page-range>
            <pub-id pub-id-type="pmid">6349345</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157516.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dieter</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Sterile pyuria: a differential diagnosis.</article-title>
            <source>Compr Ther</source>
            <year>2000</year>
            <season>Fall</season>
            <volume>26</volume>
            <issue>3</issue>
            <fpage>150</fpage>
            <page-range>150-2</page-range>
            <pub-id pub-id-type="pmid">10984817</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157516.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bendig</surname>
                <given-names>DW</given-names>
              </name>
            </person-group>
            <article-title>The Differential Diagnosis of Sterile Pyuria in Pediatric Patients: A Review.</article-title>
            <source>Glob Pediatr Health</source>
            <year>2021</year>
            <volume>8</volume>
            <fpage>2333794X21993712</fpage>
            <pub-id pub-id-type="pmid">34017902</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157516.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huppert</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Biro</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lan</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mortensen</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Reed</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Slap</surname>
                <given-names>GB</given-names>
              </name>
            </person-group>
            <article-title>Urinary symptoms in adolescent females: STI or UTI?</article-title>
            <source>J Adolesc Health</source>
            <year>2007</year>
            <month>May</month>
            <volume>40</volume>
            <issue>5</issue>
            <fpage>418</fpage>
            <page-range>418-24</page-range>
            <pub-id pub-id-type="pmid">17448399</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157516.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hooker</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Mold</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Sterile pyuria in patients admitted to the hospital with infections outside of the urinary tract.</article-title>
            <source>J Am Board Fam Med</source>
            <year>2014</year>
            <season>Jan-Feb</season>
            <volume>27</volume>
            <issue>1</issue>
            <fpage>97</fpage>
            <page-range>97-103</page-range>
            <pub-id pub-id-type="pmid">24390891</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157516.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alwall</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Lohi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>A population study on renal and urinary tract diseases. II. Urinary deposits, bacteriuria and ESR on screening and medical examination of selected cases.</article-title>
            <source>Acta Med Scand</source>
            <year>1973</year>
            <month>Dec</month>
            <volume>194</volume>
            <issue>6</issue>
            <fpage>529</fpage>
            <page-range>529-35</page-range>
            <pub-id pub-id-type="pmid">4773454</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157516.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goonewardene</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Persad</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Sterile pyuria: a forgotten entity.</article-title>
            <source>Ther Adv Urol</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>7</volume>
            <issue>5</issue>
            <fpage>295</fpage>
            <page-range>295-8</page-range>
            <pub-id pub-id-type="pmid">26425144</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157516.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Glen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Prashar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hawary</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Sterile pyuria: a practical management guide.</article-title>
            <source>Br J Gen Pract</source>
            <year>2016</year>
            <month>Mar</month>
            <volume>66</volume>
            <issue>644</issue>
            <fpage>e225</fpage>
            <page-range>e225-7</page-range>
            <pub-id pub-id-type="pmid">26917663</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157516.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wise</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Schlegel</surname>
                <given-names>PN</given-names>
              </name>
            </person-group>
            <article-title>Sterile pyuria.</article-title>
            <source>N Engl J Med</source>
            <year>2015</year>
            <month>Mar</month>
            <day>12</day>
            <volume>372</volume>
            <issue>11</issue>
            <fpage>1048</fpage>
            <page-range>1048-54</page-range>
            <pub-id pub-id-type="pmid">25760357</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157516.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Figueiredo</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Lucon</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Urogenital tuberculosis: update and review of 8961 cases from the world literature.</article-title>
            <source>Rev Urol</source>
            <year>2008</year>
            <season>Summer</season>
            <volume>10</volume>
            <issue>3</issue>
            <fpage>207</fpage>
            <page-range>207-17</page-range>
            <pub-id pub-id-type="pmid">18836557</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157516.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mantica</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ambrosini</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Riccardi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Vecchio</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rigatti</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>De Rose</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Van der Merwe</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Terrone</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bartoletti</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bonkat</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Genitourinary Tuberculosis: A Comprehensive Review of a Neglected Manifestation in Low-Endemic Countries.</article-title>
            <source>Antibiotics (Basel)</source>
            <year>2021</year>
            <month>Nov</month>
            <day>14</day>
            <volume>10</volume>
            <issue>11</issue>
            <pub-id pub-id-type="pmid">34827337</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157516.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lin</surname>
                <given-names>YL</given-names>
              </name>
              <name>
                <surname>Fan</surname>
                <given-names>YC</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Sue</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Hsu</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Hou</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>TW</given-names>
              </name>
            </person-group>
            <article-title>The case | Sterile pyuria and an abnormal abdominal film. "Autonephrectomy" of right kidney.</article-title>
            <source>Kidney Int</source>
            <year>2008</year>
            <month>Jan</month>
            <volume>73</volume>
            <issue>1</issue>
            <fpage>131</fpage>
            <page-range>131-3</page-range>
            <pub-id pub-id-type="pmid">18084265</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157516.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shipman</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Risinger</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Evans</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Gilbertson</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Hogan</surname>
                <given-names>DE</given-names>
              </name>
            </person-group>
            <article-title>High Prevalence of Sterile Pyuria in the Setting of Sexually Transmitted Infection in Women Presenting to an Emergency Department.</article-title>
            <source>West J Emerg Med</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>19</volume>
            <issue>2</issue>
            <fpage>282</fpage>
            <page-range>282-286</page-range>
            <pub-id pub-id-type="pmid">29560055</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157516.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tuddenham</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hamill</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Ghanem</surname>
                <given-names>KG</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and Treatment of Sexually Transmitted Infections: A Review.</article-title>
            <source>JAMA</source>
            <year>2022</year>
            <month>Jan</month>
            <day>11</day>
            <volume>327</volume>
            <issue>2</issue>
            <fpage>161</fpage>
            <page-range>161-172</page-range>
            <pub-id pub-id-type="pmid">35015033</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157516.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>FolefackKaze</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Kengne</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Pefura Yone</surname>
                <given-names>EW</given-names>
              </name>
              <name>
                <surname>NdamFemben</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Ashuntantang</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Renal function, urinalysis abnormalities and correlates among HIV-infected Cameroonians naive to antiretroviral therapy.</article-title>
            <source>Saudi J Kidney Dis Transpl</source>
            <year>2013</year>
            <month>Nov</month>
            <volume>24</volume>
            <issue>6</issue>
            <fpage>1291</fpage>
            <page-range>1291-7</page-range>
            <pub-id pub-id-type="pmid">24231506</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157516.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vinkeles Melchers</surname>
                <given-names>NV</given-names>
              </name>
              <name>
                <surname>van Dam</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Shaproski</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kahama</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Brienen</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Vennervald</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>van Lieshout</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic performance of Schistosoma real-time PCR in urine samples from Kenyan children infected with Schistosoma haematobium: day-to-day variation and follow-up after praziquantel treatment.</article-title>
            <source>PLoS Negl Trop Dis</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>8</volume>
            <issue>4</issue>
            <fpage>e2807</fpage>
            <pub-id pub-id-type="pmid">24743389</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157516.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Workowski</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Bachmann</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Johnston</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Muzny</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Reno</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zenilman</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Bolan</surname>
                <given-names>GA</given-names>
              </name>
            </person-group>
            <article-title>Sexually Transmitted Infections Treatment Guidelines, 2021.</article-title>
            <source>MMWR Recomm Rep</source>
            <year>2021</year>
            <month>Jul</month>
            <day>23</day>
            <volume>70</volume>
            <issue>4</issue>
            <fpage>1</fpage>
            <page-range>1-187</page-range>
            <pub-id pub-id-type="pmid">34292926</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157516.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rahman</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gladman</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Ibanez</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Urowitz</surname>
                <given-names>MB</given-names>
              </name>
            </person-group>
            <article-title>Significance of isolated hematuria and isolated pyuria in systemic lupus erythematosus.</article-title>
            <source>Lupus</source>
            <year>2001</year>
            <volume>10</volume>
            <issue>6</issue>
            <fpage>418</fpage>
            <page-range>418-23</page-range>
            <pub-id pub-id-type="pmid">11434577</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157516.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Herr</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Donat</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Reduced Recurrence of Low-grade Papillary Bladder Tumors Associated With Asymptomatic Bacteriuria.</article-title>
            <source>Urology</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>124</volume>
            <fpage>179</fpage>
            <page-range>179-182</page-range>
            <pub-id pub-id-type="pmid">30359714</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157516.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsukamoto</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sazuka</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hattori</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sato</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Arai</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Goto</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Imamura</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sakamoto</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ichikawa</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Relationship between Preoperative Pyuria and Bacille Calmette-Guerin Treatment in Intravesical Recurrence after Transurethral Resection of High-Risk, Non-Muscle Invasive, Bladder Carcinoma: A Retrospective Study of Human Data.</article-title>
            <source>Cancers (Basel)</source>
            <year>2023</year>
            <month>Mar</month>
            <day>07</day>
            <volume>15</volume>
            <issue>6</issue>
            <pub-id pub-id-type="pmid">36980524</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157516.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Figueiredo</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Lucon</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Srougi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Urogenital Tuberculosis.</article-title>
            <source>Microbiol Spectr</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>5</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">28087922</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
